(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

MAIVA

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: US

Quick snapshot

MAIVA

ST13

US500000090846194

Class

40

Filing

90846194

Registration

6937670

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

17

Latest update

12/27/2022

Classification

Registered

Trademark type

Combined

Nice classes

40

Filing date

07/23/2021

Registration date

12/27/2022

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

12/27/2022

Last transaction

12/27/2022

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

06/20/2020

First use in commerce

06/30/2020

Drawing code

3

Owner type

16

Owner location

Hosur, IN

Examiner

YAO, GRETTA

Law office

M90

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of a stylized representation of the wording "MAIVA" in white and outlined in black, contained within a pentagonal design in orange.

Holders and representatives

Holders

Maiva Pharma Private Limited

Representatives

WILLIAM SCOTT GOLDMAN GOLDMAN LAW GROUP

Technical classification

Nice Classes

Class 40

Vienna Codes

No Vienna codes available.

Goods and services

Class 40

Contract manufacturing services in the field of sterile injectables and pharmaceutical products

Publications

History of USPTO decisions and trademark events.

17 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

12/27/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

12/27/2022

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

11/24/2022

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

11/23/2022

SUPC

STATEMENT OF USE PROCESSING COMPLETE

11/01/2022

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

11/01/2022

IUAF

USE AMENDMENT FILED

10/14/2022

EISU

TEAS STATEMENT OF USE RECEIVED

10/14/2022

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

07/19/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

05/24/2022

PUBO

PUBLISHED FOR OPPOSITION

05/24/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

05/04/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

04/18/2022

DOCK

ASSIGNED TO EXAMINER

04/18/2022

MDSM

NOTICE OF DESIGN SEARCH CODE E-MAILED

09/24/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

09/23/2021

NWAP

NEW APPLICATION ENTERED

07/27/2021

Continuous trademark protection

Get notified about every new filing that threatens MAIVA or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.